MEDICLIN: In the first nine month of FY 2016 Group sales increase by EUR 20.8 mill. or 5.0 % up to EUR 435.2 mill. against previous years’ figure

Offenburg, 10 November, 2016 – In the first nine months of FY 2016, MEDICLIN achieved Group sales of EUR 435.2 mill. (9M 2015: EUR 414.4 mill.) thus being up EUR 20.8 mill. or 5.0 % compared with the first nine months of 2015. The occupancy rate was 88.4 % (9M 2015: 87.7 %). The Group operating result improved by EUR 0.4 mill. from EUR 17.4 mill. to EUR 17.8 mill.

Sales increase in the post-acute and acute segment and in the business area nursing care

In the post-acute segment sales amounted to EUR 262.9 mill and were EUR 15.3 mill.or 6.2 % higher than in the same period of the previous year. This growth was driven by the good utilisation of capacities in neurology, acute neurology, psychosomatics, orthopaedics and geriatrics. The post-acute segment result improved from EUR 15.8 mill. up to 18.8 mill. The segment-EBIT-margin was 7.2 % (9M 2015: 6.4 %).

In the acute segment sales increased by EUR 4.7 mill or 3.1 % up to EUR 158.3 mill. Sales of the second and third quarter of 2016 were significantly above the comparable previous year’s quarters. Higher expenses led to a decrease of the segment result from EUR 7.2 mill. to EUR 5.2 mill. The segment-EBIT-margin declined from 4.7 % to 3.3 %.

Sales in the nursing care business area increased by EUR 0.5 mill. up to EUR 10.9 mill. on the back of an improvement of the occupancy rate (9M 2016: 96.2 %; 9M 2015: 95.6 %).

In the first nine months of 2016, EUR 18.2 mill. (gross) was invested, thereof financed with subsidies EUR 3.1 mill. (9M 2015: EUR 20.0 mill. thereof with subsidies EUR 1.7 mill.). Cash and cash equivalents as of 30 September 2016 amounted to EUR 40.5 mill. (31.12.2015: EUR 29.5 mill.). The equity ratio was 49.0 % (31.12.2015: 51.3 %).

MEDICLIN employed an average of 6,604 employees, calculated on the basis of full-time staff, in the first nine months of 2016 (9M 2015: 6,500 full-time employees).

Outlook

The business performance in the first nine months of the 2016 financial year indicates that the sales target of 3.0 % growth announced for the Group will be exceeded. The Management Board anticipates sales growth in the range of approximately 4.5 %. Provided the post-acute segment continues to perform well, Group EBIT will be in line with the forecast range (guidance: Group EBIT between EUR 24 mill. and EUR 26 mill.).

Key figures and yoy comparison for the Group and the segments

About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)

MEDICLIN is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MEDICLIN has a total capacity of approximately 8,000 beds. MEDICLIN’s facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MEDICLIN has approximately 9,300 employees.

MEDICLIN ─ a company of the Asklepios Group